Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease.

Autor: Changela M; Department of Internal Medicine, One Brooklyn Health System/Interfaith Medical Center, Brooklyn, NY 11213, United States. changelamadhav@gmail.com., Pandey S; Department of Internal Medicine, One Brooklyn Health System/Interfaith Medical Center, Brooklyn, NY 11213, United States., Bahirwani J; Department of Gastroenterology, St. Luke's University Health Network, Bethlehem, PA 18015, United States., Patel N; Department of Gastroenterology, St. Luke's University Health Network, Bethlehem, PA 18015, United States., Kaneriya M; Department of Internal Medicine, One Brooklyn Health System/Interfaith Medical Center, Brooklyn, NY 11213, United States., Basida SD; Department of Internal Medicine, University of Missouri, Columbia, MO 65212, United States., Shah A; Department of Internal Medicine, Bronxcare Health System, Bronx, NY 10457, United States., Thakur R; Department of Internal Medicine, Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY 10461, United States., Bodrya K; Department of Internal Medicine, Lehigh Valley Health Network, Easton, PA 18045, United States., Jai Kumar Ahuja S; Department of Data Sciences, Sarepta Therapeutics, Cambridge, MA 02124, United States., Schneider Y; Department of Gastroenterology, St. Luke's University Health Network, Bethlehem, PA 18015, United States.

Publikováno v: World journal of gastrointestinal pharmacology and therapeutics [World J Gastrointest Pharmacol Ther] 2024 Nov 05; Vol. 15 (6), pp. 95532.